Article
Molecular Pathways: Niches in Metastatic Dormancy
23 Apr 2014
Abstract excerpt
Despite the best available treatments for primary tumors, cancer can return, even after a long disease-free interval. During this period, cancer cells are believed to lie dormant in either primary sites, metastatic sites, or independent sites like bone marrow, effectively escaping adjuvant cytotoxic treatments. To date, little is known about how these cells transition to dormancy, or how they are reactivated if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
